pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker AQST. Primary therapeutic focus areas include Epilepsy, Allergic Reaction, Nausea and Vomiting, Postoperative
Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
Riluzole Oral Soluble film (ROSF) 50 mg
Phase 2 · small molecule · Amyotrophic Lateral Sclerosis
Riluzole Oral Soluble film (ROSF) 50 mg for Amyotrophic Lateral Sclerosis is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 17MO1R-0012
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aquestive Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Amyotrophic Lateral Sclerosis
- Status
- terminated
- Trials
- 1